Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) EBIT per Share : ¥0.38 (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co EBIT per Share?

Shijiazhuang Yiling Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2024 was ¥0.23. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.38.

During the past 12 months, the average EBIT per Share Growth Rate of Shijiazhuang Yiling Pharmaceutical Co was -81.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 6.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 30.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 23.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Shijiazhuang Yiling Pharmaceutical Co's EBIT per Share or its related term are showing as below:

SZSE:002603' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -30.3 Med: 15.3 Max: 62.9
Current: 6.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shijiazhuang Yiling Pharmaceutical Co was 62.90% per year. The lowest was -30.30% per year. And the median was 15.30% per year.

SZSE:002603's 3-Year EBIT Growth Rate is ranked worse than
51.74% of 864 companies
in the Drug Manufacturers industry
Industry Median: 7.25 vs SZSE:002603: 6.60

Shijiazhuang Yiling Pharmaceutical Co's EBIT for the three months ended in Mar. 2024 was ¥378 Mil.

Shijiazhuang Yiling Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co EBIT per Share Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.43

0.85

0.93

1.68

1.03

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.88	0.29	0.11	-0.25	0.23

Shijiazhuang Yiling Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Shijiazhuang Yiling Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1723.112	/	1670.635
=	1.03

Shijiazhuang Yiling Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	378.009	/	1670.852
=	0.23

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.38

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Shijiazhuang Yiling Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN

Website

http://www.yiling.cn/

Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.

Executives

Zhang Qiu Lian	Directors, executives
Han Yue Zhi	Executives
Zhao Shao Hua	Executives
Wang Wei	Executives
Gao Xue Dong	Supervisors
Wu Yi Ling	Director
Gao Xiu Qiang	Executives
Wu Xiang Jun	Directors, executives
Guo Shuang Geng	Director
Wang Hua	Securities Affairs Representative
Dai Feng Xiang	Directors, executives
Liu Gen Wu	Supervisors
Wang Wei Ping	Directors, executives
Xu Wei Dong	Director
Wu Rui	Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines